Welcome
The Tara Miller Melanoma Center at the Abramson Cancer Center of the University of Pennsylvania is a comprehensive center that unites research, clinical care, education, and outreach programs to improve the lives of patients with melanoma. Despite tremendous advances in melanoma therapy, current therapies do not cure every patient. Many patients are still suffering and dying from melanoma. The Tara Miller Melanoma Center is dedicated to overcoming this challenge.
We are committed to providing exceptional care to all of our patients with melanoma and other types of skin cancers. Using a multidisciplinary approach, we deliver personalized care, integrating and connecting with providers from Dermatology, Medical Oncology, Surgical Oncology, Radiation Oncology, and Pathology. We also collaborate with basic, translational, and population scientists who study new ways to prevent, diagnose, and treat melanoma. The Center supports innovative research to truly change the trajectory of the disease for an individual patient. The Tara Miller Melanoma Center is a place where patients and their families can turn to for education and find up to date information regarding the best treatments for melanoma.
The Tara Miller Melanoma Center was established in 2019 with generous support from Debbie and George Miller in honor of their daughter, Tara Miller. As Dr. Bob Vonderheide, the Director of the Abramson Cancer Center said, “The number of people who were moved by Tara’s courage and her character is second only the number of lives that will be forever changed by her legacy”.
13th Annual Make the Best of It Bash--Save the Date!
23rd Focus on Melanoma Patient Conference -- Register Now!
When: May 8, 2026 7:30AM-1:30PM
Where: In person (location to be announced) or Virtually
Intended Audience: Those at risk and anyone affected by melanoma, family members, caregivers, advocates, members of the public.
Event Details
Register Now
Dr. Lynn Schuchter calls for early cancer detection at World Cancer Day event
On February 4, the Botswana–UPenn Partnership marked World Cancer Day with an event honoring cancer survivors and educating the community. Speaking at the program, Lynn Schuchter, MD—director of the Tara Miller Melanoma Center—underscored that early cancer screening is vital, noting that timely diagnosis improves survival and helps curb rising cancer‑related deaths.
Penn Medicine Melanoma Specialists Honored by Friends of the American Association for Cancer Research Foundation
The Friends of the American Association for Cancer Research (AACR) Foundation’s annual Party with a Purpose honors individuals whose experiences with cancer have allowed them to advocate for new research and treatments. This year’s event celebrates progress in melanoma research. Lynn Schuchter, MD, the Madlyn and Leonard Abramson Professor of Clinical Oncology and director of the Tara Miller Melanoma Center, is the 2025 Scientific Achievement Honoree. Alexander Huang, MD, an assistant professor of Hematology-Oncology, is the 2025 Early Career Investigator Honoree.
TIL Therapy Now Available!
TIL therapy is a type of immunotherapy that uses your body's own T cells (lymphocytes) to find and eliminate cancer cells. This new treatment is now available at Penn for eligible patients with advanced/metastatic melanoma that has not responded to targeted therapies or other immunotherapies. To schedule an appointment with our Penn melanoma care team for evaluation, please contact: 215-615-5858.
3D Imaging at Penn Dermatology
Penn Dermatology Oncology Center (PennDOC) has introduced an innovative, a non-invasive 3D whole body photography system into our clinical practices and is now being used in research programs.
This new technology uses 92 cameras to capture images of the entire body’s skin in less than a few seconds. Converted into a 3D avatar of the patient, the images are then analyzed by AI, which provides data on lesion characteristics (e.g., diameter, border irregularity, color) and a risk assessment of irregularities.
System-integrated dermatoscopy allows investigation of individual skin lesion surface structure and color. With serial 3D images, it highlights pigmentary changes in existing lesions and identifies new lesions, providing the opportunity to monitor the progression of skin irregularities over time.
This system is ideal for patients who have an extensive history of multiple melanomas and other skin cancers.
To schedule an appointment with our Penn melanoma and skin cancer care team to discuss eligibility and availability of this service, please contact: 215-662-4062.
Please note that most health insurance providers are not covering this service at this time, so patients may be responsible for the costs.